Martingale Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-2,555
| Closed | -$310K | – | 1014 |
|
|
2017
Q1 | $310K | Sell |
2,555
-1,029
| -29% | -$125K | ﹤0.01% | 877 |
|
|
2016
Q4 | $439K | Sell |
3,584
-2,062
| -37% | -$253K | 0.01% | 845 |
|
|
2016
Q3 | $692K | Sell |
5,646
-1,318
| -19% | -$162K | 0.01% | 756 |
|
|
2016
Q2 | $814K | Sell |
6,964
-304
| -4% | -$35.5K | 0.01% | 570 |
|
|
2016
Q1 | $1.01M | Sell |
7,268
-2,961
| -29% | -$412K | 0.02% | 487 |
|
|
2015
Q4 | $1.95M | Sell |
10,229
-2,601
| -20% | -$496K | 0.04% | 310 |
|
|
2015
Q3 | $2.01M | Buy |
12,830
+1,360
| +12% | +$213K | 0.05% | 305 |
|
|
2015
Q2 | $2.07M | Sell |
11,470
-1,056
| -8% | -$191K | 0.05% | 323 |
|
|
2015
Q1 | $2.17M | Buy |
12,526
+200
| +2% | +$34.7K | 0.05% | 322 |
|
|
2014
Q4 | $2.28M | Buy |
12,326
+3,258
| +36% | +$603K | 0.06% | 305 |
|
|
2014
Q3 | $1.5M | Buy |
9,068
+1,100
| +14% | +$182K | 0.05% | 354 |
|
|
2014
Q2 | $1.25M | Sell |
7,968
-11
| -0.1% | -$1.72K | 0.04% | 440 |
|
|
2014
Q1 | $1.21M | Buy |
7,979
+126
| +2% | +$19.2K | 0.04% | 430 |
|
|
2013
Q4 | $1.04M | Buy |
7,853
+397
| +5% | +$52.8K | 0.04% | 521 |
|
|
2013
Q3 | $867K | Sell |
7,456
-3,900
| -34% | -$454K | 0.03% | 583 |
|
|
2013
Q2 | $1.05M | Buy |
+11,356
| New | +$1.05M | 0.04% | 463 |
|